| P/E (FY) | — | Sales (TTM) | $1,000 |
| Earnings (TTM) | -$14.3M | ROE | −114.16% |
| Net Margin | −51035.71% | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | $67.5M | Trading Days | 634 |
| 52W High | 1.57 |
| 52W Low | 0.39 |
| % Off High | −17.20% |
| YTD | 14.04% | 1Y | 202.33% |
| Since incept. (ann.) | 11.60% |
| Ann. Volatility (1Y) | 96.17% | Ann. Volatility (3Y) | 94.83% |
| Sharpe (1Y) | 1.62 | Sharpe (3Y) | 0.57 |
| Max Drawdown (1Y) | −50.68% | Max Drawdown (3Y) | −73.47% |
| Beta (3Y, vs SPY) | 1.31 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| RNTX | Rein Therapeutics, Inc. | $66.9M | — |
| OSTX | OS Therapies Inc | $66.8M | — |
| PLRX | PLIANT THERAPEUTICS, INC. | $66.3M | — |
| IBIO | iBio, Inc. | $69.1M | — |
| ACRV | Acrivon Therapeutics, Inc. | $65.9M | — |
| XBIT | XBiotech Inc. | $69.2M | — |
| MNOV | MEDICINOVA INC | $65.5M | — |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | $65.4M | 8.8 |
| CLNN | Clene Inc. | $63.8M | — |
| HYFT | MindWalk Holdings Corp. | $63.5M | — |
| RFL | Rafael Holdings, Inc. | $61.8M | — |
| GANX |
| Gain Therapeutics, Inc. |
| $73.8M |
| — |
